Trial Profile
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2013
Price :
$35
*
At a glance
- Drugs Anamorelin (Primary)
- Indications Anorexia; Cachexia
- Focus Therapeutic Use
- Sponsors Helsinn Therapeutics; Rejuvenon; Sapphire Therapeutics
- 28 Nov 2013 New trial record